Literature DB >> 20882300

[Validation of the new version of the minimal documentation system (MIDOS) for patients in palliative care : the German version of the edmonton symptom assessment scale (ESAS)].

S Stiel1, M E Matthes, L Bertram, C Ostgathe, F Elsner, L Radbruch.   

Abstract

BACKGROUND: repeated self-assessment of symptoms and problems of patients is required for quality assurance in palliative care. In Germany, the Minimal Documentation System (MIDOS) has been designed specifically for palliative care patients. To adapt MIDOS as a German version of the Edmonton Symptom Assessment Scale (ESAS) a revised version of MIDOS(2) has now been validated. Two original items on average and highest pain intensity (11-step NRS) were replaced by one item on pain intensity on a 4-step VRS and the assessment of vomitus, lack of appetite and depressive mood were added to the assessment of nausea, dyspnoea, constipation, weakness, tiredness, anxiety, others and well-being which were already part of the original version.
METHOD: all patients admitted to the palliative care unit were asked to participate voluntarily in this study. MIDOS(2), the German versions of the ESAS and the quality of life questionnaire EORTC QLQ-C15-Pal were completed on the same day during their inpatient stay. MIDOS(2) was repeated on the next day.
RESULTS: from August 2009 to March 2010, 60 patients (55% men, 45% women; mean age = 64.3, range = 23.6-92.4 years) treated in the palliative care unit completed the study. Self-assessment with MIDOS(2) was reported to burden the patients only slightly (mean burden = 1.1, range: 0 = no to 10 = maximum burden on a NRS), application of MIDOS(2) took between 1 and 7 min (mean duration = 2.4 min) and 61.7% of the patients preferred MIDOS(2) (with VRS) to ESAS (30%) (with NRS) for routine daily documentation. External criterion validity by inter-item correlations of MIDOS(2) with ESAS varied between r = .533 (anxiety) and .881 (nausea) and between r = .348 (depressive mood) and .717 (constipation) for the corresponding items of the EORTC QLQ-C15-Pal. Test-retest reliability between the sum scores of symptoms and problems reported in MIDOS(2) on the first day and on the second day was .688, and r = .573 for well-being.
CONCLUSION: MIDOS(2) can be recommended for routine daily documentation in palliative care because of low burden, little expenditure of time and high participation of patients. Statistical evaluation indicated good external validity and reliability.

Entities:  

Mesh:

Year:  2010        PMID: 20882300     DOI: 10.1007/s00482-010-0972-5

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


  23 in total

1.  [Quality assurance in palliative medicine--results of the core documentation of 1999-2002].

Authors:  Gabriele Lindena; Friedemann Nauck; Claudia Bausewein; Karl Neuwöhner; Oliver Heine; Dieter Schulenberg; Lukas Radbruch
Journal:  Z Arztl Fortbild Qualitatssich       Date:  2005

2.  Performance status assessment in cancer patients.

Authors:  C Conill; E Verger; M Salamero
Journal:  Cancer       Date:  1990-04-15       Impact factor: 6.860

3.  Correlation of patient and caregiver ratings of cancer pain.

Authors:  S A Grossman; V R Sheidler; K Swedeen; J Mucenski; S Piantadosi
Journal:  J Pain Symptom Manage       Date:  1991-02       Impact factor: 3.612

4.  The burden of symptoms among community-dwelling older persons with advanced chronic disease.

Authors:  Lisa M Walke; William T Gallo; Mary E Tinetti; Terri R Fried
Journal:  Arch Intern Med       Date:  2004-11-22

5.  Comparing patients' and their physicians' assessments of pain.

Authors:  M Hodgkins; D Albert; L Daltroy
Journal:  Pain       Date:  1985-11       Impact factor: 6.961

6.  Validation of the German version of the brief fatigue inventory.

Authors:  Lukas Radbruch; Rainer Sabatowski; Frank Elsner; Jan Everts; Tito Mendoza; Charles Cleeland
Journal:  J Pain Symptom Manage       Date:  2003-05       Impact factor: 3.612

7.  The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress.

Authors:  R K Portenoy; H T Thaler; A B Kornblith; J M Lepore; H Friedlander-Klar; E Kiyasu; K Sobel; N Coyle; N Kemeny; L Norton
Journal:  Eur J Cancer       Date:  1994       Impact factor: 9.162

8.  Drugs in palliative care: results from a representative survey in Germany.

Authors:  Friedemann Nauck; Christoph Ostgathe; Eberhard Klaschik; Claudia Bausewein; Martin Fuchs; Gabriele Lindena; Karl Neuwöhner; Dieter Schulenberg; Lukas Radbruch
Journal:  Palliat Med       Date:  2004-03       Impact factor: 4.762

9.  What is palliative care in Germany? Results from a representative survey.

Authors:  Lukas Radbruch; Friedemann Nauck; Martin Fuchs; Karl Neuwöhner; Dieter Schulenberg; Gabriele Lindena
Journal:  J Pain Symptom Manage       Date:  2002-06       Impact factor: 3.612

10.  [MIDOS--validation of a minimal documentation system for palliative medicine].

Authors:  L Radbruch; R Sabatowski; G Loick; I Jonen-Thielemann; F Elsner; E Hörmann
Journal:  Schmerz       Date:  2000-08       Impact factor: 1.107

View more
  27 in total

1.  [Validation of the Bonn test for knowledge in palliative care (BPW)].

Authors:  D Pfister; M Müller; S Müller; M Kern; R Rolke; L Radbruch
Journal:  Schmerz       Date:  2011-12       Impact factor: 1.107

Review 2.  The Edmonton Symptom Assessment System 25 Years Later: Past, Present, and Future Developments.

Authors:  David Hui; Eduardo Bruera
Journal:  J Pain Symptom Manage       Date:  2016-12-29       Impact factor: 3.612

3.  [Well-being of patients receiving specialized palliative care at home or in hospital].

Authors:  M Jansky; G Lindena; F Nauck
Journal:  Schmerz       Date:  2012-02       Impact factor: 1.107

4.  Validation of the Edmonton Symptom Assessment System in Korean patients with cancer.

Authors:  Jung Hye Kwon; Seung-Hyun Nam; Sujin Koh; Young Seon Hong; Kyung Hee Lee; Sang-Won Shin; David Hui; Kyun Woo Park; So Young Yoon; Ji Yun Won; Gary Chisholm; Eduardo Bruera
Journal:  J Pain Symptom Manage       Date:  2013-04-28       Impact factor: 3.612

5.  Predictors of outpatients' request for palliative care service at a medical oncology clinic of a German comprehensive cancer center.

Authors:  Mitra Tewes; Teresa Rettler; Nathalie Wolf; Jörg Hense; Martin Schuler; Martin Teufel; Mingo Beckmann
Journal:  Support Care Cancer       Date:  2018-05-05       Impact factor: 3.603

6.  Screening for symptom burden and supportive needs of patients with glioblastoma and brain metastases and their caregivers in relation to their use of specialized palliative care.

Authors:  Bettina Seekatz; Matthias Lukasczik; Mario Löhr; Katja Ehrmann; Michael Schuler; Almuth F Keßler; Silke Neuderth; Ralf-Ingo Ernestus; Birgitt van Oorschot
Journal:  Support Care Cancer       Date:  2017-03-29       Impact factor: 3.603

7.  Recommending early integration of palliative care - does it work?

Authors:  Jan Gaertner; Juergen Wolf; Sebastian Frechen; Ursula Klein; Dennis Scheicht; Martin Hellmich; Karin Toepelt; Jan-Peter Glossmann; Christoph Ostgathe; Michael Hallek; Raymond Voltz
Journal:  Support Care Cancer       Date:  2011-02-19       Impact factor: 3.603

8.  [End of life care in general practice: results of an observational survey with general practitioners].

Authors:  I Gágyor; A Lüthke; M Jansky; J-F Chenot
Journal:  Schmerz       Date:  2013-06       Impact factor: 1.107

9.  Is breathlessness what the professional says it is? Analysis of patient and professionals' assessments from a German nationwide register.

Authors:  Steffen T Simon; Nadine Altfelder; Bernd Alt-Epping; Claudia Bausewein; Vera Weingärtner; Raymond Voltz; Christoph Ostgathe; Lukas Radbruch; Gabriele Lindena; Friedemann Nauck
Journal:  Support Care Cancer       Date:  2014-02-19       Impact factor: 3.603

10.  Symptom screening for constipation in oncology: getting to the bottom of the matter.

Authors:  Madeline Li; Caroline Sanders; Chieh-Hsin Lee; Bryan Gascon; Alyssa Macedo; Sean Molloy; Stephane Laframboise; Yvonne W Leung
Journal:  Support Care Cancer       Date:  2018-10-30       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.